Serum FGF21 Levels Predict the MACE in Patients With Myocardial Infarction After Coronary Artery Bypass Graft Surgery

OBJECTIVES: Prognosis evaluation in myocardial infarction (MI) patients with major adverse clinical events (MACE) who have undergone coronary artery bypass graft (CABG) is greatly important to identify high-risk patients. Elevated metabolic hormone fibroblast growth factor 21 (FGF21) is associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Wei, Li, Dan, Shi, Yaru, Yu, Ning, Yan, Yu, Zhang, Yingchao, Yu, Qiongli, Li, Yulin, Du, Jie, Lin, Zhuofeng, Wu, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020287/
https://www.ncbi.nlm.nih.gov/pubmed/35463746
http://dx.doi.org/10.3389/fcvm.2022.850517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020287/
https://www.ncbi.nlm.nih.gov/pubmed/35463746
http://dx.doi.org/10.3389/fcvm.2022.850517

Ejemplares similares